The space launch and satellite tech company continues to grow its business.
The stock, however, remains an underperformer, failing to reflect this growth.
RKLB shares are currently undervalued, but will likely remain volatile.
By most measures, shares of space launch specialist Rocket Lab (NASDAQ:RKLB) should be rallying in light of its recently released third-quarter numbers.
Revenue grew 73% year over year to $268 million versus analyst estimates of only $257.2 million during the three months ended in September, while gross profits improved from $57.3 million in Q3 of last year to $90.1 million. Its backlog jumped 52% from the second quarter's figure as well, reaching nearly $3.6 billion.
Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our analysts, we’re only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
Rocket Lab even raised the price for future flights aboard its Neutron rocket, which still hasn't made an actual test flight proving it works. The space launch company's still losing money, to be clear, but that's not unusual or unexpected for a young outfit like this one.
And yet, after a brief bullish bump the next day, Rocket Lab stock has since fizzled out, leaving it right where it's been stuck since peeling back from May's peak -- more than 50% below that record high.
What gives? Volatility is nothing new here. However, this may be an instance where some of the pessimism surrounding an up-and-comer has taken on a life of its own, preventing its stock from recovering. Time can eventually solve that problem as the company proves itself. Rocket Lab should be doing this soon enough.
It's not difficult to understand how and why investors are so easily discouraged by Rocket Lab here. Its smaller Electron rocket has now made 99 successful launches. But its bigger medium-lift Neutron rocket, capable of putting 14 tons worth of payload into low Earth orbit, which was initially expected to begin flying last year, has had its inaugural flight repeatedly pushed all the way back to next year, if not later. Shareholders are understandably frustrated.
Their level of frustration may not be fully merited, though. Last quarter's revenue and backlog growth wasn't a one-off. That pace of progress has been the norm for a while now, and it should remain the norm for the foreseeable future as the company continues to add launch capacity by expanding its fleet of Electron rockets.
Full-year revenue guidance of between $972 million and $992 million is more than 60% better than 2025's top line, which improved 2024's sales by 38%, and those were 78% above 2023's figure. Gross margins have also grown in step with the company's top line.
Image source: Rocket Lab's Q3 2026 earnings presentation.
It's also worth noting that the majority of Rocket Lab's revenue still comes from satellite technology and construction services rather than launch, the former of which is a more reliable and lower-risk business.
Both arms are lining up more and more future business, too. The company signed over $1 billion in new launch contracts last quarter alone -- up 263% year over year -- while it simultaneously won $470 million in new space systems business, up 512% from Q3 2025.
The past couple of quarters have marked a real turning point for Rocket Lab, establishing that it's not just another flash-in-the-pan story. It's the real deal, with a legitimate shot at winning its fair share of the satellite manufacturing and launch vehicle market, which Mordor Intelligence says is set to grow from $40 billion this year to $98 billion by 2031.
But there’s still that pesky Neutron rocket.
There's no denying Rocket Lab has disappointed investors by repeatedly -- and somewhat indefinitely -- delaying the inaugural launch of its medium-lift rocket. Indirectly adding to this frustration is CFO Adam Spice's comment during the company's third-quarter earnings conference call that adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) "will turn positive within 6 months of that first successful [Neutron] test flight," with cash flow expected to turn positive shortly thereafter. The implication is that the company won't be able to turn a profit until that happens, whenever that is.
It is apt to eventually happen, though, leading to Spice's expected fiscal result. The company raised the total price of a single Neutron launch from $55 million to $70 million during the third quarter, by the way, and prospective customers didn't even seem to bat an eye.
Again, Rocket Lab inked $1 billion worth of future launch business in Q3 alone, including eight rides on a Neutron rocket that's yet to make its very first flight. It's a testament to the demand for this service and to the faith in Rocket Lab's know-how.
Image source: Getty Images.
The rub for investors here is time. It's going to take a while longer to get Neutron off the ground (figuratively and literally), but it's not exactly clear how much longer. Much can happen in the meantime. Even if it doesn't matter in the long run, short-term responses to headlines could rattle the stock. RKLB won't be easy to stick with between now and then.
Taking a small shot on Rocket Lab because of Neutron's potential still isn't a bad bet, though, if you can stomach the inevitable volatility in the interim.
This might help: Although the majority of investors remain hesitant to step back in following the June-July pullback, the analyst community remains confident. Its collective rating on RKLB is still a strong buy, with a consensus price target of $96.80, nearly 50% above this ticker's current price. That's not a bad tailwind with which to start a new trade.
Most investors think they missed the AI boat because they didn't buy Nvidia in 2005.
But according to our analysts, we’re only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout, a massive technology build-out that Google’s CEO says could be more profound than fire or electricity.
While everyone watches the chip designers, one "backbone" company provides the critical technology that Nvidia and AMD literally cannot function without. We’ve detailed this under-the-radar player in our new AI Playbook.
Continue »
James Brumley has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Rocket Lab. The Motley Fool has a disclosure policy.